Journal article
Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy
Journal of surgical oncology, Vol.128(2), pp.280-288
08/2023
DOI: 10.1002/jso.27287
PMCID: PMC10330210
PMID: 37073788
Abstract
Outcomes for pancreatic adenocarcinoma (PDAC) remain difficult to prognosticate. Multiple models attempt to predict survival following the resection of PDAC, but their utility in the neoadjuvant population is unknown. We aimed to assess their accuracy among patients that received neoadjuvant chemotherapy (NAC).
We performed a multi-institutional retrospective analysis of patients who received NAC and underwent resection of PDAC. Two prognostic systems were evaluated: the Memorial Sloan Kettering Cancer Center Pancreatic Adenocarcinoma Nomogram (MSKCCPAN) and the American Joint Committee on Cancer (AJCC) staging system. Discrimination between predicted and actual disease-specific survival was assessed using the Uno C-statistic and Kaplan-Meier method. Calibration of the MSKCCPAN was assessed using the Brier score.
A total of 448 patients were included. There were 232 (51.8%) females, and the mean age was 64.1 years (±9.5). Most had AJCC Stage I or II disease (77.7%). For the MSKCCPAN, the Uno C-statistic at 12-, 24-, and 36-month time points was 0.62, 0.63, and 0.62, respectively. The AJCC system demonstrated similarly mediocre discrimination. The Brier score for the MSKCCPAN was 0.15 at 12 months, 0.26 at 24 months, and 0.30 at 36 months, demonstrating modest calibration.
Current survival prediction models and staging systems for patients with PDAC undergoing resection after NAC have limited accuracy.
Details
- Title: Subtitle
- Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy
- Creators
- Clayton T Marcinak - University of Wisconsin–MadisonWilliam F Parker - University of ChicagoAlexander A Parikh - Mays Cancer Center at UT Health San AntonioJashodeep Datta - University of MiamiShishir K Maithel - Emory University School of MedicineDavid A Kooby - Emory University School of MedicineMark E Burkard - University of Wisconsin–MadisonHong Jin Kim - University of North Carolina at Chapel HillMichael T LeCompte - University of North Carolina at Chapel HillMajid Afshar - University of Wisconsin–MadisonMatthew M Churpek - University of Wisconsin–MadisonSyed Nabeel Zafar - University of Wisconsin–Madison
- Resource Type
- Journal article
- Publication Details
- Journal of surgical oncology, Vol.128(2), pp.280-288
- DOI
- 10.1002/jso.27287
- PMID
- 37073788
- PMCID
- PMC10330210
- NLM abbreviation
- J Surg Oncol
- ISSN
- 0022-4790
- eISSN
- 1096-9098
- Grant note
- R01 HL157262 / NHLBI NIH HHS K08 HL150291 / NHLBI NIH HHS T32 HG002760 / NHGRI NIH HHS P30 CA014520 / NCI NIH HHS R01 GM141068 / NIGMS NIH HHS NIH HHS R01 CA234904 / NCI NIH HHS
- Language
- English
- Date published
- 08/2023
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984701255802771
Metrics
16 Record Views